These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10166245)

  • 1. Formulary management at a tertiary care teaching hospital.
    Mutnick AH; Ross MB
    Pharm Pract Manag Q; 1997 Apr; 17(1):63-87. PubMed ID: 10166245
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of criteria developed before formulary addition to evaluate misoprostol use.
    Rice KM; LeRoy ML; Ivey MF; Deck C; Krstenansky P
    Am J Hosp Pharm; 1992 Mar; 49(3):629-31. PubMed ID: 1598943
    [No Abstract]   [Full Text] [Related]  

  • 3. Procedure for evaluating nonformulary drug orders.
    Jay GT; Quercia RA; Gousse G; Chow MS; Quintiliani R
    Am J Hosp Pharm; 1993 Dec; 50(12):2554-6. PubMed ID: 8122692
    [No Abstract]   [Full Text] [Related]  

  • 4. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving an effective committee through reorganization: the Ohio State University Hospital's experience.
    Lewis RP; Moore TD
    Hosp Formul; 1991 Feb; 26(2):120-30. PubMed ID: 10109143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How a longstanding P & T Committee identifies and meets current therapeutic challenges.
    Stross J; de Leon R; Volger B
    Hosp Formul; 1991 Sep; 26(9):717-22, 724. PubMed ID: 10114003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of a P & T Committee in a community teaching hospital.
    Cooke DH; Kessler J
    Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P & T Committee interview: Establishing and maintaining a dynamic formulary.
    Rostand S; Lazarus H
    Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria-based DUE aids in selection of preferred agent.
    Drea EJ
    Hosp Formul; 1991 Nov; 26 Suppl D():25-7. PubMed ID: 10136562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R; Gousse GC; Chow MS
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P & T Committee interview: strategies to ensure an effective formulary system.
    Riff L; Hutchinson R
    Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an antimicrobial formulary for a university teaching hospital system.
    Marr JJ; Baum KF; Chapman AD; Douglas JM; Ellison RT; Marman GW; Perlman D; Riley HE; Sintek CD; Woltemath DA
    Am J Hosp Pharm; 1992 Jun; 49(6):1481-4. PubMed ID: 1529996
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceuticals in Australia: priorities in a teaching hospital.
    Kearney BJ
    Physician Exec; 1993; 19(5):63-7. PubMed ID: 10130953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of a clinical pharmacology consult service as a formulary management tool.
    Albertson T; Musallam N; Tharratt S; Romac D; Foulke G; Mowers R; Panecek E
    Hosp Formul; 1993 Aug; 28(8):699-702, 707. PubMed ID: 10127748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulary streamlining through therapeutic class review.
    Guerriero SE; Neff JL
    Hosp Pharm; 1995 Apr; 30(4):287-90. PubMed ID: 10141869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs.
    Kile DM; McGrath ME; Schindel LP
    Hosp Formul; 1987 Feb; 22(2):176, 178, 181. PubMed ID: 10280289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P&T Committee overview: Brigham and Women's Hospital.
    Shea BF; Churchill WW; Powell SH; Cooley TW; Maguire JH
    Pharm Pract Manag Q; 1998 Jan; 17(4):76-83. PubMed ID: 10174751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.